Sprout Health provides access to compounded GLP-1 medications prepared by licensed U.S. pharmacies. Compounded semaglutide and tirzepatide are not approved by the FDA and have not been evaluated for safety, effectiveness, or quality by the FDA. Branded medications such as Ozempic® (semaglutide) and Wegovy® (semaglutide) are FDA-approved. Ozempic® is approved for type 2 diabetes but may be prescribed off-label for weight management at a provider’s discretion. Wegovy® is FDA-approved for weight loss. All prescription products available through Sprout Health require an online medical evaluation with an independent licensed healthcare provider, who will determine if treatment is appropriate. Medications are prescribed only if clinically suitable, and the actual packaging may differ from images shown. Physicians may prescribe compounded formulations when appropriate to meet individual patient needs or in cases of drug shortages. If you request a prescription, Sprout Health will facilitate access to a consultation with a licensed medical provider. The provider will review your health information and decide whether to issue a prescription. If approved, your medication will be filled by a partner pharmacy, unless you specify a different licensed pharmacy of your choice. By engaging with Sprout Health, you consent to the use of your information for operational and marketing purposes. This may include participation in advertising campaigns on platforms such as Google, Meta, or similar services, using hashed or de-identified data for audience targeting and exclusion. You may opt out of marketing communications at any time by following the unsubscribe instructions in our emails or by contacting [email protected]